ENTITY

Myungin Pharmaceutical (MYUNGIN KS)

14
Analysis
Health Care • South Korea

•13 May 2026 19:19

Primer: Myungin Pharmaceutical (MYUNGIN KS) - May 2026

Dominant CNS Market Leader: Myungin Pharmaceutical is the undisputed leader in South Korea's Central Nervous System (CNS) therapeutic market,...

Logo
111 Views
Share
bullish•Hanmi Pharm
•09 Feb 2026 05:20

KOSPI Size Indices: Market Volatility Narrows Spread (A Bit)

There could be 42 migrations across categories in March, plus new listings being added. The recent market volatility has narrowed the...

Logo
413 Views
Share
bearish•LG H&H
•05 Jan 2026 05:20

KOSPI Size Indices: Small-To-Mid Migrations Running Up

There could be 37 migrations across categories in March, plus new listings being added. The small-to-mid cap migrations have continued to move...

Logo
438 Views
Share
•27 Nov 2025 07:02

KOSPI Size Indices: Lots of Change as Averaging Starts

There could be 34 migrations for the KOSPI Size Indices in March. Among new listings, there could be 1 LargeCap add, 2 MidCap adds and 2 SmallCap...

Logo
811 Views
Share
bullish•LG Chem
•25 Oct 2025 16:18

Top 10 Korean Stock Picks and Key Catalysts Bi-Weekly (24 October to 7 November 2025)

Top 10 picks in this bi-weekly include Samsung Life Insurance, Samsung C&T, KT&G, LG CNS, Samchully, Hyundai Elevator, Korea Zinc, LG Chem (Pref),...

Logo
1k Views
Share
x